$16.46 -0.38 (-2.26%)
11/27/2009 1:00 PM

BioMarin Pharmaceutical, Inc. (BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Featured Broker Partners